741709-59-1 Usage
Uses
Used in Organic Synthesis:
1-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)ethanone is used as a reagent in organic synthesis for the formation of carbon-carbon and carbon-heteroatom bonds, facilitating the creation of complex molecular structures that are essential in the development of new compounds.
Used in Pharmaceutical Synthesis:
In the pharmaceutical industry, 1-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)ethanone serves as a precursor for the synthesis of various drugs, contributing to the development of novel therapeutic agents that address a range of health conditions.
Used in Agrochemical Production:
1-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)ethanone is also utilized in the production of agrochemicals, where it aids in the synthesis of pesticides and other agricultural products that are crucial for crop protection and enhancement of agricultural yields.
Used in Fine Chemicals Production:
1-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)ethanone is used in the production of fine chemicals, which are high-purity chemicals used in various applications, including research, diagnostics, and the formulation of specialty products.
Used in Material Manufacturing:
In the manufacturing of materials such as polymers and coatings, 1-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)ethanone acts as an intermediate, playing a critical role in the development of innovative materials with specific properties for diverse applications.
Check Digit Verification of cas no
The CAS Registry Mumber 741709-59-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,4,1,7,0 and 9 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 741709-59:
(8*7)+(7*4)+(6*1)+(5*7)+(4*0)+(3*9)+(2*5)+(1*9)=171
171 % 10 = 1
So 741709-59-1 is a valid CAS Registry Number.
741709-59-1Relevant academic research and scientific papers
CARBOXYLIC ACID AROMATIC AMIDES AS ANTAGONISTS OF BRADYKININ B1 RECEPTOR
-
Page/Page column 137, (2018/07/29)
The present invention relates to carboxylic acid aromatic amides compounds of general formula (I) as described and defined herein, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing
FUSED TRICYCLIC COMPOUNDS AS mTOR INHIBITORS
-
Page/Page column 64, (2013/03/26)
The present invention relates to certain pyrazolo[1,5-a]pyrrolo[3,2-e]pyrimidine and dipyrazolopyrimidine compounds of Formula (I) as inhibitors of mammalian Target Of Rapamycin (mTOR) kinase, which is also known as FRAP, RAFT, RAPT or SEP. The compounds
FUSED TRICYCLIC INHIBITORS OF MAMMALIAN TARGET OF RAPAMYCIN
-
Page/Page column 55; 56, (2012/03/26)
This invention relates to novel fused tricyclic compounds that are inhibitors of mammalian Target of Rapamycin (mTOR) kinase, which is also known as FRAP, RAFT, RAPT or SEP, and are useful in the treatment of cellular proliferative diseases, for example c
HETEROARYLOXYCARBOCYCLYL COMPOUNDS AS PDE10 INHIBITORS
-
Page/Page column 68, (2011/12/02)
Heteroaryloxycarbocyclyl compounds of formula (I), and compositions containing them, and processes for preparing such compounds. Provided herein also are methods of treating disorders or diseases treatable by inhibition of PDE10, such as obesity, non-insulin dependent diabetes, schizophrenia, Huntington's Disease, bipolar disorder, obsessive -compulsive disorder, and the like. Formula (I)
